The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 beta

Citation
R. Gantier et al., The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 beta, NEUROSCI L, 283(3), 2000, pp. 217-220
Citations number
21
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROSCIENCE LETTERS
ISSN journal
03043940 → ACNP
Volume
283
Issue
3
Year of publication
2000
Pages
217 - 220
Database
ISI
SICI code
0304-3940(20000414)283:3<217:TPLMOP>2.0.ZU;2-8
Abstract
Determination of the effects of presenilin 1 (PSEN1) mutations, involved in autosomal dominant early-onset Alzheimer's disease (ADEOAD), on the intera ction between PSEN1 and binding proteins is essential to determine which in teractions are involved in Alzheimer's disease (AD) pathogenesis. The PSEN1 binding protein glycogen synthase kinase-3 beta (GSK-3 beta) has been cons idered as a key protein in AD pathogenesis since GSK-3 beta phosphorylates tau and hyperphosphorylated tau is a main component of neurofibrillary tang les associated to AD. We show here, using surface plasmonic resonance, that the pathogenic L392V mutation, identified in a large French ADEOAD pedigre e including 39 affected members, leads to a decreased affinity to GSK-3 bet a. We conclude therefore that the increase of affinity of PSEN1 to GSK-3 be ta reported in previous studies is not a common effect of pathogenic mutati ons associated to ADEOAD. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.